Northern Trust Corp Cyma Bay Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.63 - $24.47 $1.04 Million - $2.02 Million	82,575 Added 8.2%	1,090,087 $25.7 Million
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $348,747 - $565,831	32,113 Added 3.29%	1,007,512 $15 Million
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $5.72 Million - $8.39 Million	765,922 Added 365.64%	975,399 $10.7 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $406,884 - $663,608	69,198 Added 49.33%	209,477 $1.83 Million
Q4 2022 Feb 13, 2023	SELL	$3.22 - $6.27 $740 - $1,442	-230 Reduced 0.16%	140,279 $879,000
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $4,210 - $6,460	1,520 Added 1.09%	140,509 $492,000
Q2 2022 Aug 12, 2022	SELL	$1.72 - $3.39 $1.02 Million - $2.01 Million	-592,728 Reduced 81.01%	138,989 $410,000
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $348,022 - $457,329	125,640 Added 20.73%	731,717 $2.28 Million
Q4 2021 Feb 08, 2022	SELL	$3.23 - $4.6 $20,688 - $29,462	-6,405 Reduced 1.05%	606,077 $2.05 Million
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $89,331 - $113,788	-25,744 Reduced 4.03%	612,482 $2.24 Million
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $202,547 - $252,927	-51,408 Reduced 7.45%	638,226 $2.78 Million
Q1 2021 May 12, 2021	SELL	$4.23 - $6.55 $169,568 - $262,569	-40,087 Reduced 5.49%	689,634 $3.13 Million
Q4 2020 Feb 11, 2021	SELL	$5.73 - $9.03 $77,068 - $121,453	-13,450 Reduced 1.81%	729,721 $4.19 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $106,150 - $231,484	-31,973 Reduced 4.12%	743,171 $5.38 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $92,725 - $279,492	-65,763 Reduced 7.82%	775,144 $2.71 Million
Q1 2020 May 14, 2020	BUY	$1.25 - $2.02 $32,146 - $51,948	25,717 Added 3.15%	840,907 $1.24 Million
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $26,178 - $116,720	-19,683 Reduced 2.36%	815,190 $1.6 Million
Q3 2019 Nov 13, 2019	BUY	$5.12 - $7.21 $298,511 - $420,364	58,303 Added 7.51%	834,873 $4.27 Million
Q2 2019 Aug 13, 2019	BUY	$6.05 - $13.66 $227,129 - $512,823	37,542 Added 5.08%	776,570 $5.56 Million
Q1 2019 May 13, 2019	BUY	$8.16 - $13.42 $260,418 - $428,285	31,914 Added 4.51%	739,028 $9.82 Million
Q4 2018 Feb 12, 2019	SELL	$6.54 - $11.74 $62,215 - $111,682	-9,513 Reduced 1.33%	707,114 $5.57 Million
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $407,466 - $543,788	37,451 Added 5.51%	716,627 $7.94 Million
Q2 2018 Sep 18, 2018	BUY	$10.66 - $14.38 $241,822 - $326,210	22,685 Added 3.46%	679,176 $9.12 Million
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $5.78 Million - $7.8 Million	542,642 Added 476.63%	656,491 $8.81 Million
Q1 2018 May 09, 2018	BUY	$9.0 - $15.16 $258,525 - $435,471	28,725 Added 33.74%	113,849 $1.48 Million
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $24,244 - $29,428	-3,161 Reduced 3.58%	85,124 $783,000
Q3 2017 Nov 13, 2017	BUY	$5.95 - $8.26 $525,295 - $729,234	88,285	88,285 $711,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account